Jonathan W. Friedberg, M.D., M.M.Sc.

Jonathan W. Friedberg, M.D., M.M.Sc.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642

Administrative: (585) 275-4911
Fax: (585) 273-5761
Office: (585) 275-5823

Journal Articles

Showing all 113 journal articles available.

2014 Nov 24
Mir MA, Maurer MJ, Ziesmer SC, Slager SL, Habermann T, Macon WR, Link BK, Syrbu S, Witzig T, Friedberg JW, Press O, LeBlanc M, Cerhan JR, Novak A, Ansell S. "Elevated serum levels of IL-2R, IL-1RA and CXCL9 are associated with a poor prognosis in follicular lymphoma." Blood. 2014 Nov 24; Epub 2014 Nov 24.
2014 Nov 13
Persky DO, Miller TP, Unger JM, Spier CM, Puvvada S, Stea BD, Press OW, Constine LS, Barton KP, Friedberg JW, LeBlanc M, Fisher RI. "Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high risk limited stage aggressive B-cell lymphoma: SWOG S0313." Blood. 2014 Nov 13; Epub 2014 Nov 13.
2014 Nov 5
Nastoupil LJ, Sinha R, Byrtek M, Ziemiecki R, Taylor M, Friedberg JW, Koff JL, Link BK, Cerhan JR, Dawson KL, Flowers CR. "Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States." Leukemia & lymphoma. 2014 Nov 5; :1-8. Epub 2014 Nov 05.
2014 Oct 1
Friedberg JW. "End of rituximab maintenance for low-tumor burden follicular lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Oct 1; 32(28):3093-5. Epub 2014 Aug 25.
2014 Oct
Gopal AK, Bartlett NL, Forero-Torres A, Younes A, Chen R, Friedberg JW, Matous JV, Shustov AR, Smith SE, Zain J, O'Meara MM, Fanale MA. "Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacy." Leukemia & lymphoma. 2014 Oct; 55(10):2328-34. Epub 2014 Feb 24.
2014 Sep 15
Rahmani M, Aust MM, Benson EC, Wallace L, Friedberg J, Grant S. "PI3K/mTOR inhibition markedly potentiates HDAC inhibitor activity in NHL cells through BIM- and MCL-1-dependent mechanisms in vitro and in vivo." Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Sep 15; 20(18):4849-60. Epub 2014 Jul 28.
2014 Sep
Casulo C, Vose JM, Ho WY, Kahl B, Brunvand M, Goy A, Kasamon Y, Cheson B, Friedberg JW. "A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokinetics." Clinical immunology : the official journal of the Clinical Immunology Society. 2014 Sep; 154(1):37-46. Epub 2014 Jun 11.
2014 Sep
Jahangiri S, Barr P, Friedberg J. "Emerging protein kinase inhibitors for the treatment of non-Hodgkin's lymphoma." Expert opinion on emerging drugs. 2014 Sep; 19(3):367-83. Epub 2014 Jun 24.
2014 Aug 21
Barr PM, Miller TP, Friedberg JW, Peterson DR, Baran AM, Herr M, Spier CM, Cui H, Roe DJ, Persky DO, Casulo C, Littleton J, Schwartz M, Puvvada S, Landowski TH, Rimsza LM, Dorr RT, Fisher RI, Bernstein SH, Briehl MM. "Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma." Blood. 2014 Aug 21; 124(8):1259-65. Epub 2014 Jul 11.
2014 Aug
Friedberg JW, Unger JM, Burack WR, Gopal AK, Raju RN, Nademanee AP, Kaminski MS, Li H, Press OW, Miller TP, Fisher RI. "R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433." British journal of haematology. 2014 Aug; 166(3):382-9. Epub 2014 Apr 18.
2014 Aug
Younes A, Thieblemont C, Morschhauser F, Flinn I, Friedberg JW, Amorim S, Hivert B, Westin J, Vermeulen J, Bandyopadhyay N, de Vries R, Balasubramanian S, Hellemans P, Smit JW, Fourneau N, Oki Y. "Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study." The Lancet. Oncology. 2014 Aug; 15(9):1019-26. Epub 2014 Jul 17.
2014 Aug
Mbulaiteye SM, Morton LM, Sampson JN, Chang ET, Costas L, de Sanjosé S, Lightfoot T, Kelly J, Friedberg JW, Cozen W, Marcos-Gragera R, Slager SL, Birmann BM, Weisenburger DD. "Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project." Journal of the National Cancer Institute. Monographs. 2014 Aug; 2014(48):106-14.
2014 Aug
Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjosé S, Smedby KE, Chiu BC, Zhang Y, Mbulaiteye SM, Monnereau A, Turner JJ, Clavel J, Adami HO, Chang ET, Glimelius B, Hjalgrim H, Melbye M, Crosignani P, di Lollo S, Miligi L, Nanni O, Ramazzotti V, Rodella S, Costantini AS, Stagnaro E, Tumino R, Vindigni C, Vineis P, Becker N, Benavente Y, Boffetta P, Brennan P, Cocco P, Foretova L, Maynadié M, Nieters A, Staines A, Colt JS, Cozen W, Davis S, de Roos AJ, Hartge P, Rothman N, Severson RK, Holly EA, Call TG, Feldman AL, Habermann TM, Liebow M, Blair A, Cantor KP, Kane EV, Lightfoot T, Roman E, Smith A, Brooks-Wilson A, Connors JM, Gascoyne RD, Spinelli JJ, Armstrong BK, Kricker A, Holford TR, Lan Q, Zheng T, Orsi L, Dal Maso L, Franceschi S, La Vecchia C, Negri E, Serraino D, Bernstein L, Levine A, Friedberg JW, Kelly JL, Berndt SI, Birmann BM, Clarke CA, Flowers CR, Foran JM, Kadin ME, Paltiel O, Weisenburger DD, Linet MS, Sampson JN. "Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project." Journal of the National Cancer Institute. Monographs. 2014 Aug; 2014(48):130-44.
2014 Jul 15
Hutchinson K, Jahangiri S, Calvi LM, Barr P, Friedberg JW, Kelly JL. "Impact of dietary supplements, obesity and treatment initiation on serum vitamin D levels in patients with lymphoma." Leukemia & lymphoma. 2014 Jul 15; :1-4. Epub 2014 Jul 15.
2014 Jul 1
Herrera AF, Crosby-Thompson A, Friedberg JW, Abel GA, Czuczman MS, Gordon LI, Kaminski MS, Millenson MM, Nademanee AP, Niland JC, Rodig SJ, Rodriguez MA, Zelenetz AD, LaCasce AS. "Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network." Cancer. 2014 Jul 1; 120(13):1993-9. Epub 2014 Apr 04.
2014 Jul 1
Weeks JC, Uno H, Taback N, Ting G, Cronin A, D'Amico TA, Friedberg JW, Schrag D. "Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study." Annals of internal medicine. 2014 Jul 1; 161(1):20-30.
2014 Jun 15
Nastoupil LJ, Sinha R, Byrtek M, Zhou X, Taylor MD, Friedberg JW, Link BK, Cerhan JR, Dawson K, Flowers CR. "The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States." Cancer. 2014 Jun 15; 120(12):1830-7. Epub 2014 Mar 25.
2014 Feb 6
Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN. "An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era." Blood. 2014 Feb 6; 123(6):837-42. Epub 2013 Nov 21.
2014 Jan 20
Canellos GP, Rosenberg SA, Friedberg JW, Lister TA, Devita VT. "Treatment of Hodgkin lymphoma: a 50-year perspective." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Jan 20; 32(3):163-8.
2014 Jan 1
Friedberg JW, Mahadevan D, Cebula E, Persky D, Lossos I, Agarwal AB, Jung J, Burack R, Zhou X, Leonard EJ, Fingert H, Danaee H, Bernstein SH. "Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Jan 1; 32(1):44-50. Epub 2013 Sep 16.
2014
Casulo C, Burack WR, Friedberg JW. "Transformed follicular non Hodgkin lymphoma." Blood. 2014 Epub 2014 Dec 11.
2014
Dabaja BS, Vanderplas AM, Crosby-Thompson AL, Abel GA, Czuczman MS, Friedberg JW, Gordon LI, Kaminski M, Niland J, Millenson M, Nademanee AP, Zelenetz A, LaCasce AS, Rodriguez MA. "Radiation for diffuse large B-cell lymphoma in the rituximab era: Analysis of the National Comprehensive Cancer Network lymphoma outcomes project." Cancer. 2014 Epub 2014 Dec 09.
2013 Nov
Ban-Hoefen M, Vanderplas A, Crosby-Thompson AL, Abel GA, Czuczman MS, Gordon LI, Kaminski MS, Kelly J, Millenson M, Nademanee AP, Rodriguez MA, Zelenetz AD, Niland J, LaCasce AS, Friedberg JW. "Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database." British journal of haematology. 2013 Nov; 163(4):487-95. Epub 2013 Sep 20.
2013 Oct 31
Stiff PJ, Unger JM, Cook JR, Constine LS, Couban S, Stewart DA, Shea TC, Porcu P, Winter JN, Kahl BS, Miller TP, Tubbs RR, Marcellus D, Friedberg JW, Barton KP, Mills GM, LeBlanc M, Rimsza LM, Forman SJ, Fisher RI. "Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma." The New England journal of medicine. 2013 Oct 31; 369(18):1681-90.
2013 Oct 15
Evens AM, Vanderplas A, LaCasce AS, Crosby AL, Nademanee AP, Kaminski MS, Abel GA, Millenson M, Czuczman MS, Rodriguez MA, Niland J, Zelenetz AD, Gordon LI, Friedberg JW. "Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project." Cancer. 2013 Oct 15; 119(20):3662-71. Epub 2013 Aug 06.
2013 Oct
Abou-Nassar KE, Vanderplas A, Friedberg JW, Abel GA, Niland J, Rodriguez MA, Czuczman MS, Millenson M, Crosby A, Gordon LI, Zelenetz AD, Kaminski M, Lacasce AS. "Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1-2 follicular lymphoma and its impact on initial treatment strategy in the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes database." Leukemia & lymphoma. 2013 Oct; 54(10):2155-62. Epub 2013 Feb 25.
2013 Sep
Reid R, Friedberg JW. "Management of marginal zone lymphoma." Oncology. 2013 Sep; 27(9):840, 842, 844.
2013 Aug
Herman SE, Barr PM, McAuley EM, Liu D, Wiestner A, Friedberg JW. "Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia." Leukemia. 2013 Aug; 27(8):1769-73. Epub 2013 Feb 06.
2013 Apr
Vose JM, Friedberg JW, Waller EK, Cheson BD, Juvvigunta V, Fritsch H, Petit C, Munzert G, Younes A. "The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study." Leukemia & lymphoma. 2013 Apr; 54(4):708-13. Epub 2012 Oct 04.
2013 Feb 20
Gordon LI, Hong F, Fisher RI, Bartlett NL, Connors JM, Gascoyne RD, Wagner H, Stiff PJ, Cheson BD, Gospodarowicz M, Advani R, Kahl BS, Friedberg JW, Blum KA, Habermann TM, Tuscano JM, Hoppe RT, Horning SJ. "Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Feb 20; 31(6):684-91. Epub 2012 Nov 26.
2013 Feb
Nooka AK, Nabhan C, Zhou X, Taylor MD, Byrtek M, Miller TP, Friedberg JW, Zelenetz AD, Link BK, Cerhan JR, Dillon H, Sinha R, Shenoy PJ, Levy D, Dawson K, Hirata JH, Flowers CR. "Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices." Annals of oncology : official journal of the European Society for Medical Oncology. 2013 Feb; 24(2):441-8. Epub 2012 Oct 05.
2013 Jan 20
Press OW, Unger JM, Rimsza LM, Friedberg JW, LeBlanc M, Czuczman MS, Kaminski M, Braziel RM, Spier C, Gopal AK, Maloney DG, Cheson BD, Dakhil SR, Miller TP, Fisher RI. "Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Jan 20; 31(3):314-20. Epub 2012 Dec 10.
2013
Martin P, Byrtek M, Dawson K, Ziemiecki R, Friedberg JW, Cerhan JR, Flowers CR, Link BK. "Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study." Cancer. 2013 119(23):4129-36. Epub 2013 Sep 04.
2013
Press OW, Unger JM, Rimsza LM, Friedberg JW, LeBlanc M, Czuczman MS, Kaminski M, Braziel RM, Spier C, Gopal AK, Maloney DG, Cheson BD, Dakhil SR, Miller TP, Fisher RI. "A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomab." Clinical cancer research : an official journal of the American Association for Cancer Research. 2013 19(23):6624-32. Epub 2013 Oct 15.
2012 Oct 1
Nabhan C, Byrtek M, Taylor MD, Friedberg JW, Cerhan JR, Hainsworth JD, Miller TP, Hirata J, Link BK, Flowers CR. "Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study." Cancer. 2012 Oct 1; 118(19):4842-50. Epub 2012 Mar 20.
2012 Oct 1
Friedberg JW. "Double-hit diffuse large B-cell lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Oct 1; 30(28):3439-43. Epub 2012 Sep 04.
2012 Sep 20
Friedberg JW, Byrtek M, Link BK, Flowers C, Taylor M, Hainsworth J, Cerhan JR, Zelenetz AD, Hirata J, Miller TP. "Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Sep 20; 30(27):3368-75. Epub 2012 Aug 20.
2012 Jun 1
Kumar A, Vanderplas A, LaCasce AS, Rodriguez MA, Crosby AL, Lepisto E, Czuczman MS, Nademanee A, Niland J, Gordon LI, Millenson M, Zelenetz AD, Friedberg JW, Abel GA. "Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: findings from a large national database." Cancer. 2012 Jun 1; 118(11):2944-51. Epub 2011 Oct 17.
2012 Jun
Abel GA, Vanderplas A, Rodriguez MA, Crosby AL, Czuczman MS, Niland JC, Gordon LI, Millenson M, Zelenetz AD, Friedberg JW, LaCasce AS. "High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database." Leukemia & lymphoma. 2012 Jun; 53(6):1113-6. Epub 2012 Feb 03.
2012 Jun
Friedberg JW. "Mantle cell lymphoma." Best practice & research. Clinical haematology. 2012 Jun; 25(2):131-2. Epub 2012 May 17.
2012 Jun
Noel MS, Friedberg JW, Barr PM. "Novel agents in mantle cell lymphoma." Best practice & research. Clinical haematology. 2012 Jun; 25(2):191-200. Epub 2012 Apr 30.
2012 May
Ban-Hoefen M, Kelly JL, Bernstein SH, Liesveld J, Constine L, Becker M, Milner L, Phillips G, Friedberg JW. "High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era." Leukemia & lymphoma. 2012 May; 53(5):830-5. Epub 2011 Dec 06.
2012 Apr
Keller SF, Kelly JL, Sensenig E, Andreozzi J, Oliva J, Rich L, Constine L, Becker M, Phillips G, Liesveld J, Fisher RI, Bernstein SH, Friedberg JW. "Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2012 Apr; 18(4):640-7. Epub 2011 Aug 24.
2012 Mar 1
LaCasce AS, Vandergrift JL, Rodriguez MA, Abel GA, Crosby AL, Czuczman MS, Nademanee AP, Blayney DW, Gordon LI, Millenson M, Vanderplas A, Lepisto EM, Zelenetz AD, Niland J, Friedberg JW. "Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database." Blood. 2012 Mar 1; 119(9):2093-9. Epub 2012 Jan 10.
2012 Mar
Barr PM, Wei C, Roger J, Schaefer-Cutillo J, Kelly JL, Rosenberg AF, Jung J, Sanz I, Friedberg JW. "Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion." Clinical immunology : the official journal of the Clinical Immunology Society. 2012 Mar; 142(3):237-42. Epub 2012 Jan 05.
2011 Sep
Dasmahapatra G, Lembersky D, Son MP, Attkisson E, Dent P, Fisher RI, Friedberg JW, Grant S. "Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivo." Molecular cancer therapeutics. 2011 Sep; 10(9):1686-97. Epub 2011 Jul 12.
2011 Jul
Phillips GL, Bernstein SH, Liesveld JL, Abboud CN, Becker MW, Constine LS, Ifthikharuddin JJ, Loughner JE, Milner LA, Vesole DH, Friedberg JW. "A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Jul; 17(7):1033-42. Epub 2010 Nov 11.
2011 May
Das P, Ng A, Constine LS, Advani R, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ. "ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II." Journal of the American College of Radiology : JACR. 2011 May; 8(5):302-8.
2011 Mar 10
Friedberg JW, Vose JM, Kelly JL, Young F, Bernstein SH, Peterson D, Rich L, Blumel S, Proia NK, Liesveld J, Fisher RI, Armitage JO, Grant S, Leonard JP. "The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma." Blood. 2011 Mar 10; 117(10):2807-12. Epub 2011 Jan 14.
2010 Aug
Kelly JL, Friedberg JW, Calvi LM, van Wijngaarden E, Fisher SG. "A case-control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adults." Cancer causes & control : CCC. 2010 Aug; 21(8):1265-75. Epub 2010 Apr 07.
2010 Jul
Burack WR, Laughlin TS, Friedberg JW, Spence JM, Rothberg PG. "PCR assays detect B-lymphocyte clonality in formalin-fixed, paraffin-embedded specimens of classical hodgkin lymphoma without microdissection." American journal of clinical pathology. 2010 Jul; 134(1):104-11.
2010 May 1
Biswas T, Dhakal S, Chen R, Hyrien O, Bernstein S, Friedberg JW, Fisher RI, Liesveld J, Phillips G, Constine LS. "Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era." International journal of radiation oncology, biology, physics. 2010 May 1; 77(1):79-85. Epub 2009 Aug 03.
2010 Apr 1
Friedberg JW, Sharman J, Sweetenham J, Johnston PB, Vose JM, Lacasce A, Schaefer-Cutillo J, De Vos S, Sinha R, Leonard JP, Cripe LD, Gregory SA, Sterba MP, Lowe AM, Levy R, Shipp MA. "Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia." Blood. 2010 Apr 1; 115(13):2578-85. Epub 2009 Nov 17.
2010
Ng A, Constine LS, Advani R, Das P, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ. "ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma." Current problems in cancer. 2010 34(3):211-27.
2010
Cheson BD, Friedberg JW, Kahl BS, Van der Jagt RH, Tremmel L. "Bendamustine produces durable responses with an acceptable safety profile in patients with rituximab-refractory indolent non-Hodgkin lymphoma." Clinical lymphoma, myeloma & leukemia. 2010 10(6):452-7.
2009 Oct
Ban-Hoefen M, Bernstein SH, Bisognano JD, Pryor JG, Friedberg JW. "Symptomatic intracardiac diffuse large B-cell lymphoma." American journal of hematology. 2009 Oct; 84(10):683-5.
2009 Sep 1
Dhakal S, Biswas T, Liesveld JL, Friedberg JW, Phillips GL, Constine LS. "Patterns and timing of initial relapse in patients subsequently undergoing transplantation for Hodgkin's lymphoma." International journal of radiation oncology, biology, physics. 2009 Sep 1; 75(1):188-92. Epub 2009 Feb 26.
2009 Sep
Friedberg JW. "Bendamustine in chronic lymphocytic leukemia: the future is combination therapy." Leukemia & lymphoma. 2009 Sep; 50(9):1399-400.
2009 Aug
Friedberg JW, Kelly JL, Neuberg D, Peterson DR, Kutok JL, Salloum R, Brenn T, Fisher DC, Ronan E, Dalton V, Rich L, Marquis D, Sims P, Rothberg PG, Liesveld J, Fisher RI, Coffman R, Mosmann T, Freedman AS. "Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma." British journal of haematology. 2009 Aug; 146(3):282-91. Epub 2009 Jun 10.
2009 Jun
Brown JR, Friedberg JW, Feng Y, Scofield S, Phillips K, Dal Cin P, Joyce R, Takvorian RW, Fisher DC, Fisher RI, Liesveld J, Marquis D, Neuberg D, Freedman AS. "A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas." British journal of haematology. 2009 Jun; 145(6):741-8. Epub 2009 Mar 30.
2009 Apr
Mendler JH, Friedberg JW. "Salvage therapy in Hodgkin's lymphoma." The oncologist. 2009 Apr; 14(4):425-32. Epub 2009 Apr 02.
2009 Feb
McLaughlin P, Friedberg JW. "Seeking wisdom from the Seer." Leukemia & lymphoma. 2009 Feb; 50(2):145-7.
2009
Toothaker SR, Kelly J, Ciminello L, Hoelzer D, Holte H, LaCasce AS, Mead , Thomas D, van Imhoff GW, Kahl BS, Cheson BD, Magrath IT, Fisher RI, Friedberg JW. "Outcomes of patients with Burkitt lymphoma older than age 40 treated with aggressive chemotherapeutic regimens". Clinical Lymphoma and Myeloma. 2009; in press.
2008 Jan 10
Friedberg JW, Cohen P, Chen L, Robinson KS, Forero-Torres A, La Casce AS, Fayad LE, Bessudo A, Camacho ES, Williams ME, van der Jagt RH, Oliver JW, Cheson BD. "Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 10; 26(2):204-10.
2008
Friedberg JW, Cohen P, Chen L, Robinson K, Forero-Torres A, LaCasce A, Fayad L, Bessudo A, Camacho E, Williams M, van der Jagt R, Oliver J, Loh E, Cheson BD:. "Bendamustine in patients with rituximab-refractory and alkylator-refractory, indolent non-Hodgkin's lymphoma: results from a phase I multicenter, single-agent study." Jounal of Clinical Oncology. 2008; 26: 204-10.
2008
Friedberg JW, Jacobsen E, Neuberg D, Kutok J, Munoz O, Boussiotis V, Reynolds H, Fisher DC, Szot A, Van den Abbeele AD, Freedman AS. "Targeting the follicular lymphoma microenvironment through blockade of TNF-alpha with etanercept." Leukemia and Lymphoma. 2008; 49: 902-09.
2008
Walker AR, Kleiner A, Rich L, Conners C, Fisher RI, Anolik J, Friedberg JW. "Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma." Cancer Investigation. 2008; 26: 431-3.
2008
Mendler J, Kelly J, Voci S, Marquis D, Rich L, Rossi RM, Bernstein SH, Jordan CT, Liesveld J, Fisher RI, Friedberg JW. "Bortezomib and gemcitabine in relapsed or refractory Hodgkin lymphoma." Annual Oncology. 2008; 19: 1759-64.
2008
LaCasce AS, Kho ME, Friedberg JW, Niland J, Abel G, Rodriguez MA, Czuczman M, Millenson M, Weeks J. "Comparison of Referring and Final Pathology for Non-Hodgkin's Lymphoma Patients in the National Comprehensive Cancer Network (NCCN)". Journal of Clinical Oncology. 2008; 26: 5107-12.
2008
Kho ME, Lepisto E, Niland JC, Friedberg JW, LaCasce AS, Weeks JC. "Reliability of staging, prognosis, and comorbidity data collection in the National Comprehensive Cancer Network (NCCN) non-Hodgkin lymphoma (NHL) multi-institutional outcomes database." Cancer. 2008; 113: 3209-12.
2008
Bernstein SH, Unger J, LeBlanc M, Friedberg JW, Miller T, Fisher RI. "CNS events in patients with aggressive non Hodgkin's lymphoma: the role of CNS prophylaxis." Journal of Clinical Oncology. 2008; in press.
2008
Walker A, Komrokji R, Ifthikharuddin J, Messina P, Mulford D, Becker M, Friedberg JW, Oliva J, Phillips G, Liesveld J, Abboud CA. "Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML." Leukemia Research. 2008; 32: 1830-6.
2008
Friedberg JW, Taylor MD, Cerhan JR, Flowers C, Dillon H, Farber CM, Rogers E, Hainsworth J, Wong EK, Vose JM, Zelenetz AD, Link BK. "Follicular lymphoma in the United States: First report of the National LymphoCare Study." Journal of Clinical Oncology. 2008; : in press.
2008
Ban-Hoefen M, Bernstein S, Bisognano JD, Pryor JG, Friedberg JW. "Symptomatic Intracardiac Diffuse large B-cell lymphoma". American Journal of Hematology. 2008; : in press.
2008
Dhakal S, Biswas T, Liesveld J, Friedberg JW, Phillips G, Constine LS. "Patterns and Timing of initial relapse in patients transplanted for Hodgkin lymphoma." International Journal of Radiation Oncology,Biology,Physics. 2008; in press.
2007 Jun
Bartlett NL, Niedzwiecki D, Johnson JL, Friedberg JW, Johnson KB, van Besien K, Zelenetz AD, Cheson BD, Canellos GP, . "Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804." Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Jun; 18(6):1071-9. Epub 2007 Apr 10.
2007
Anolik J, Friedberg JW, Zheng B, Barnard J, Owen T, Cushing E, Kelly J, Milner ECB, Fisher RI, Sanz I. "B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny." Clinical Immunology. 2007; 122: 139-45.
2007
Leonard JP, Friedberg JW*, Younes A, Fisher D, Gordon LI, Moore J, Czuczman M, Miller T, Stiff P, Cheson BD, Forero-Torres A, Chieffo N, McKinney B, Finucane D, Molina A. "A Phase I/II study of galiximab in combination with rituximab for relapsed or refractory follicular lymphoma". Annual Oncology. 2007; 18: 1216-23.
2007
Bartlett, NL, Niedzwiecki, D, Johnson, JL, Friedberg, JW, Johnson KB, van Besien K, Zelenetz AD, Cheson, BD, Canellos GP. "Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma". Annual Oncology. 2007; 18: 1071-9.
2006 May
Vargas RL, Fallone E, Felgar RE, Friedberg JW, Arbini AA, Andersen AA, Rothberg PG. "Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experience." Leukemia research. 2006 May; 30(5):547-51. Epub 2005 Oct 24.
2006
Friedberg JW, Fisher RI. "Diffuse large B-cell NHL." Cancer treatment and research. 2006 131:121-40.
2005 Apr 1
Brown JR, Yeckes H, Friedberg JW, Neuberg D, Kim H, Nadler LM, Freedman AS. "Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Apr 1; 23(10):2208-14. Epub 2005 Mar 07.
2005 Jan 15
Friedberg JW, Kim H, McCauley M, Hessel EM, Sims P, Fisher DC, Nadler LM, Coffman RL, Freedman AS. "Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-alpha/beta-inducible gene expression, without significant toxicity." Blood. 2005 Jan 15; 105(2):489-95. Epub 2004 Sep 09.
2005
Fisher RI, Friedberg JW. "Update on mantle cell lymphoma and diffuse large B-cell non-Hodgkin's lymphoma." Lymphoma Annual Update 2005; Clinical Care Options. 2005; . Link
2004 Nov 1
Lyman GH, Dale DC, Friedberg J, Crawford J, Fisher RI. "Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Nov 1; 22(21):4302-11. Epub 2004 Sep 20.
2004 Feb
Friedberg JW, Dong DA, Li S, Kim H, Stephans K, Noonan K, Neuberg D, Gribben JG, Fisher DC, Freedman AS, Takvorian T, Jurgens R, Battle TE, Frank DA. "Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo." Leukemia research. 2004 Feb; 28(2):139-47.
2004 Feb
Brown JR, Gaudet G, Friedberg JW, Neuberg D, Mauch P, Kutok JL, Takvorian T, Fisher DC, Gribben JG, Kim H, Nadler LM, Freedman AS. "Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphoma." Leukemia & lymphoma. 2004 Feb; 45(2):315-20.
2004 Jan
Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, Mauch PM, Canellos GP, van den Abbeele AD. "FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison." Leukemia & lymphoma. 2004 Jan; 45(1):85-92.
2004
Friedberg JW, Fisher RI. "Iodine-131 tositumomab (Bexxar): radioimmunoconjugate therapy for indolent and transformed B-cell non-Hodgkin's lymphoma." Expert Rev Anticancer Therapy. 2004; 4: 18-26. Link
2004
Phillips GL, Abboud CN, Bernstein SH, Friedberg JW, Ifthikharuddin JJ, Lancet JE, Liesveld JL, Spreng E, Johnson V, Chapman M, Vesole DH. "Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary report." Seminars in oncology. 2004 31(6 Suppl 18):59-61.
2003 Oct
Friedberg JW, Kim H, Li S, Neuberg D, Boyd K, Daley H, Fisher DC, Gribben JG, Spitzer T, Freedman AS. "Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma." Bone marrow transplantation. 2003 Oct; 32(7):681-6.
2003 Sep 1
Friedberg JW, Neuberg D, Kim H, Miyata S, McCauley M, Fisher DC, Takvorian T, Canellos GP. "Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity." Cancer. 2003 Sep 1; 98(5):978-82.
2003
Friedberg JW, Aster J, and Canellos GP.;. "Hodgkin's Disease". Blood: Principles and Practice of Hematalogy. 2003; . Link
2003
Friedberg JW, Chengazi V. "PET scans in the staging of lymphoma: current status." The oncologist. 2003 8(5):438-47.
2002 Sep 15
Ng AK, Bernardo MV, Weller E, Backstrand K, Silver B, Marcus KC, Tarbell NJ, Stevenson MA, Friedberg JW, Mauch PM. "Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors." Blood. 2002 Sep 15; 100(6):1989-96.
2002 Jun
Friedberg JW, Neuberg D, Gribben JG, Fisher DC, Canning C, Koval M, Poor CM, Green LM, Daley J, Soiffer R, Ritz J, Freedman AS. "Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphoma." British journal of haematology. 2002 Jun; 117(4):828-34.
2002 Apr 15
Ng AK, Bernardo MP, Weller E, Backstrand KH, Silver B, Marcus KC, Tarbell NJ, Friedberg J, Canellos GP, Mauch PM. "Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Apr 15; 20(8):2101-8.
2002 Jan
Gaudet G, Friedberg JW, Weng A, Pinkus GS, Freedman AS. "Breast lymphoma associated with breast implants: two case-reports and a review of the literature." Leukemia & lymphoma. 2002 Jan; 43(1):115-9.
2002
Friedberg JW and DiPiro PJ;. "Staging and pretreatment evaluation of Hodgkin's disease." Atlas of Clinical Oncology, Malignant lymphomas, Malignant Grossbard. 2002; . Link
2002
Webb IJ, Friedberg W, Gribben JG, Fisher DC, Spitzer T, Neuberg D, Jallow H, Kim H, Houde H, Monroy R, Schmittling R, Freedman AS. "Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2002 8(8):429-34.
2002
Alyea EP, Weller E, Fisher DC, Freedman AS, Gribben JG, Lee S, Schlossman RL, Stone RM, Friedberg J, DeAngelo D, Liney D, Windawi S, Ng A, Mauch P, Antin JH, Soiffer RJ. "Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2002 8(11):601-7.
2001
Friedberg JW, Neuberg D, Monson E, Jallow H, Nadler LM, Freedman AS. "The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2001 7(8):446-53.
2000 Mar
Freedman A, Friedberg JW, Gribben J. "High-dose therapy for follicular lymphoma." Oncology. 2000 Mar; 14(3):321-6, 329; discussion 330-2, 338.
1999 Oct 15
Friedberg JW, Van den Abbeele AD, Kehoe K, Singer S, Fletcher CD, Demetri GD. "Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma." Cancer. 1999 Oct 15; 86(8):1621-7.
1999 Oct
Friedberg JW, Neuberg D, Stone RM, Alyea E, Jallow H, LaCasce A, Mauch PM, Gribben JG, Ritz J, Nadler LM, Soiffer RJ, Freedman AS. "Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Oct; 17(10):3128-35.
1999 May
Friedberg JW, Freedman AS. "High-dose therapy and stem cell transplantation in follicular lymphoma." Annals of hematology. 1999 May; 78(5):203-11.
1999
Friedberg JW, Neuberg D, Gribben JG, Mauch P, Anderson KC, Soiffer RJ, Takvorian T, Fisher DC, Schlossman R, Jallow H, Kuhlman C, Ritz J, Freedman AS. "Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 1999 5(4):262-8.
1998
Viguera AC, Baldessarini RJ, Friedberg J. "Discontinuing antidepressant treatment in major depression." Harvard review of psychiatry. 1998 5(6):293-306.
1995 Jun
Friedberg JW, Frankenburg FR, Burk J, Johnson W. "Clozapine-caused eosinophilic colitis." Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 1995 Jun; 7(2):97-8.
1993
Banov MD, Tohen M, Friedberg J. "High risk of eosinophilia in women treated with clozapine." The Journal of clinical psychiatry. 1993 54(12):466-9.
1992 Sep
Friedberg JW. "From municipal hospital to medical center: Milwaukee County General Hospital, 1965-1980." Wisconsin medical journal. 1992 Sep; 91(9):547-9.
0
Friedberg JW, Ng A;. "Epidemiology of second malignancies following lymphoma therapy and screening recommendations." In Press. Link
0
Friedberg JW, Freedman AS. "Antibody and immunomodulatory agents in treatment of indolent NHL." In Press. . Link

Books

2008
McMahon B, Friedberg JW. "Lymphocyte-predominant Hodgkin's lymphoma. Evidence-based Hematology". Evidence-based Hematology. : Evidence based Hematology, 2008. in press
2008
Link BK and Friedberg JW. "Monoclonal antibodies in lymphoma: the first decade.". Seminars in Hematology. : Seminars in Hematology, 2008. 71-4
2008
Schaefer-Cutillo J., Friedberg JW. "Non-myeloablative radioimmunotherapy for lymphoma.". Seminars in Hematology. : Seminars in Hematology, 2008. 110-7
2008
Sikder M, Friedberg JW:. "Beyond rituximab: the future of monoclonal antibody in B-cell non-Hodgkin's lymphoma.". Current Oncology Reports. : Current Oncology Reports, 2008. 420-6
2008
Friedberg JW, Mauch PM, Rimsza LM, Fisher RI. ": Non-Hodgkin's lymphomas". Cancer, Principles & Practice of Oncology 8th edition. : Lippincott Williams & Wilkins, 2008. 2098-2143
2008
Friedberg JW. "Treatment of follicular non-Hodgkin's lymphoma: the old and the new.". Seminars in Hematology. : Seminars in Hematology, 2008. s2-s6
2008
Friedberg JW, Fisher RI. "Diffuse Large B cell lymphoma". Hematology/Oncology Clinics of North America. : Hematology/Oncology Clinics of North America, 2008. 941-52
2007
Schaefer-Cutillo J, Friedberg JW, Fisher RI. "Novel Concepts in Radioimmunotherapy for Non-Hodgkin's Lymphoma". Oncology. : Oncology, 2007.
2007
Barr P, Fisher RI, Friedberg JW. "Role of Bortezomib in the treatment of lymphoma.". Cancer Investigation. : Cancer Investigation, 2007. 766-75
2007
Leonard JP, Friedberg JW, Hagameister FB, Levine AM. "Combination treatment approaches and novel therapies for lymphoma.". Clinical Advancements in Hematology and Oncology 5. : Clinical Advancements in Hematology and Oncology 5, 2007. 4-20
2006
Friedberg JW, Ng, A. "Epidemiology of second malignancies following lymphoma therapy and screening recommendations.". Clinical Malignant Hematology. Sekeres, MA. : McGraw-Hill, 2006. 815-21
2006
Friedberg JW, Fisher RI. ""Diffuse Large B-cell Lymphoma"". Hodgkin and non-Hodgkin lymphoma. Leonard JP, Coleman M, editors.. : Springer, NY, USA,, 2006. 121-141
2006
Friedberg JW, Freedman AS. "Antibody and immunomodulatory agents in treatment of indolent NHL.". Current Treatment Options Oncology. : Current Treatment options Oncology, 2006. 276-84
2006
Friedberg JW, Fisher RI. "Diffuse Large B Cell NHL". Cancer Treatment Research. : Cancer Treatment Research, 2006. 121-40
2006
Friedberg JW, Swinnen LJ. "Pst-Transplant Lympoproliferative Disease". The Lymphomas. Canellos GP, Lister TA, Young BD. : Elsevier, 2006. 555-566
2006
Friedberg JW, Fisher RI. "Large-cell lymphoma, nodal, splenic". The Lymphomas. Canellos GP, Lister TA, Young BD. : Elsvier, 2006. 295-303
2006
Friedberg JW. "Hodgkin lymphoma, Diagnosis". The Lymphomas. Canellos GP, Lister TA, Young BD. : Elsvier, 2006. 476-482
2005
Friedberg JW. "Unique Toxicities and Resistance Mechanisms Associated with Monoclonal Antibody Therapy.". Hematology 2005. : American Society of Hematology Education Program Book, 2005. 329-334
2005
Fisher RI, Friedberg JW. "Update on mantle cell lymphoma and diffuse large B-cell non-Hodgkin's lymphoma.". Lymphoma Annual Update 2005. : at http://clinicaloptions.com/lymphoma2005, 2005. 121-141
2005
Friedberg JW. "Unique Toxicities and Resistance Mechanisms Associated with Monoclonal Antibody Therapy.". American Society of Hematology Education. : American Society of Hematology Education Program Book, 2005. 329-334
2005
Fisher RI, Mauch PM, Harris NL, Friedberg JW. "Non-Hodgkin's Lymphoma". Cancer, Principles & Practice of Oncology. Devita Jr VT, Hellman S, Rosenberg SA. Philadelphia, PA: Lippincott Williams & Wilkins, 2005. 1957-97
2004
Freedman AS, Friedberg JW. "Follicular lymphoma". Non-Hodgkin's Lymphoma. Philadelphia, PA: Lippincott, Williams and Wilkins, 2004.
2003
Friedberg JW, Aster J, and Canellos GP. "Hodgkin's Disease". Blood: Principles and Practice of Hematology. Philadelphia, PA: Lippincott, Williams and Wilkins, 2003.
2003
Friedberg JW. "Myelodysplasia after autologous stem cell transplantation.". Clinical Bone Marrow and Stem Cell Transplantation. : Cambridge University Press, 2003.
2003
Scadden DT and Friedberg JW. "Cancer and the Immunocompromised Host.". Clinical Practice of Hematology and Oncology. Furie B, Cassileth P, Atkins M and Mayer RJ. Philadelphia, PA: WB Saunders Company, 2003.
2002
Friedberg JW and Dipiro PJ. "Staging and pretreatment evaluation of Hodgkin's disease.". Atlas of Clinical Oncology, Malignant lymphomas, ML Grossband. Hamilton, London: B C Decker Inc., 2002.